Ellinghaus, David; Folseraas, Trine; Holm, Kristian et al.
Genome-Wide Association Analysis in Primary Sclerosing Cholangitis and Ulcerative Colitis Identifies Risk Loci at GPR35 and TCF4HEPATOLOGY. Bd. 58. H. 3. 2013 S. 1074-1083
Gerbermann, Steffen; Toenissen, Hanna E.; Weinmann, Arndt et al.
Glycosylated Hemoglobin as a novel Predictor of Renal Impairment after Orthotopic Liver TransplantationHEPATOLOGY. Bd. 58. 2013 S. 254A-254A
Drescher, Daniel G.; Kulzer, Laura; Schimanski, Carl Christoph et al.
Growth Factor Receptors in the Gastrointestinal Tract of the Rat - New Targets for Improved Anastomotic Healing?GASTROENTEROLOGY. Bd. 144. H. 5. 2013 S. S1088-S1088
Kah, Janine; Volz, Tassilo; Luetgehetmann, Marc et al.
Hemoxygenase-1 and its downstream product biliverdin suppress HCV replication and provides hepatoprotective effects in humanized uPA/SCID miceHEPATOLOGY. Bd. 58. 2013 S. 1173A-1173A
Knapstein, J.; Schwab, A.; Grimm, D. et al.
Hepatitis C Reinfection after Liver Transplantation (LT): Who can and should be treated with direct antiviral Therapy?INTERNIST. Bd. 54. 2013 S. 27-28
Giersch, K.; Luetgehetmann, M.; Volz, T. et al.
HEPATITIS DELTA INFECTION IN HUMANIZED UPA/SCID-MICE LEADS TO PRONOUNCED INDUCTION OF HUMAN-SPECIFIC INNATE IMMUNE RESPONSES AND CYTOKINE EXPRESSION IN COMPARISON TO HBV MONO-INFECTIONJOURNAL OF HEPATOLOGY. Bd. 58. 2013 S. S55-S56
Zenouzi, R.; Weismueller, T.; Huebener, P. et al.
HEPATOCELLULAR CARCINOMA DOES NOT SIGNIFICANTLY CONTRIBUTE TO THE RISK OF HEPATOBILIARY MALIGNANCY IN CIRRHOTIC PATIENTS WITH PRIMARY SCLEROSING CHOLANGITISJOURNAL OF HEPATOLOGY. Bd. 58. 2013 S. S396-S396
Nistal, Markus W.; Pace, Andrea; Klose, Hans et al.
Hepatopulmonary syndrome caused by sarcoidosis of the liver treated with transjugular intrahepatic portosystemic shuntTHORAX. Bd. 68. H. 9. 2013 S. 889-890
Otto, Gerd; Schuchmann, Marcus; Hoppe-Lotichius, Maria et al.
How to decide about liver transplantation in patients with hepatocellular carcinoma: Size and number of lesions or response to TACE?JOURNAL OF HEPATOLOGY. Bd. 59. H. 2. 2013 S. 279-284
Moehler, M.
HOW TO DEVELOP MOLECULAR TARGETED DRUGS IN GASTRIC CANCER: FIRST OR SECOND LINE?ANNALS OF ONCOLOGY. Bd. 24. 2013 S. 15-15